PT027 (albuterol/budesonide) is a potential first-in-class inhaled, fixed-dose combination of the short-acting beta2-agonist albuterol and budesonide, an inhaled corticosteroid. It is currently ...
blue reliever inhalers without the corticosteroids contained in preventative medication, saying patients should instead be offered a low-dose combination of corticosteroids and formoterol ...